Shares of SKYE About to load in some shares of SKYE. $0.12 right now, a CBD company helping find a cure for glaucoma.
Next report date
Report period
Q1 2024
EPS estimate
−0.16USD
Revenue estimate
—
−5.70USD
−37.64 MUSD
12.58 M
About Skye Bioscience, Inc.
Sector
CEO
Punit S. Dhillon
Headquarters
San Diego
Website
Employees (FY)
11
Founded
2011
FIGI
BBG00433GZN1
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include Nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SKYE is 12.99 USD — it has increased by 1.56% in the past 24 hours. Watch Skye Bioscience, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Skye Bioscience, Inc. stocks are traded under the ticker SKYE.
Skye Bioscience, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
SKYE stock is 2.59% volatile and has beta coefficient of 0.43. Track Skye Bioscience, Inc. stock price on the chart and check out the list of the most volatile stocks — is Skye Bioscience, Inc. there?
Yes, you can track Skye Bioscience, Inc. financials in yearly and quarterly reports right on TradingView.
SKYE stock has fallen by 0.08% compared to the previous week, the month change is a 7.21% fall, over the last year Skye Bioscience, Inc. has showed a 284.89% increase.
SKYE net income for the last quarter is −4.42 M USD, while the quarter before that showed −24.95 M USD of net income which accounts for 82.28% change. Track more Skye Bioscience, Inc. financial stats to get the full picture.
Today Skye Bioscience, Inc. has the market capitalization of 358.93 M, it has decreased by 8.86% over the last week.
No, SKYE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SKYE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Skye Bioscience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
SKYE reached its all-time high on Dec 12, 2014 with the price of 2750.00 USD, and its all-time low was 1.44 USD and was reached on Nov 15, 2023. View more price dynamics on SKYE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 11.00 employees. See our rating of the largest employees — is Skye Bioscience, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Skye Bioscience, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Skye Bioscience, Inc. stock shows the neutral signal. See more of Skye Bioscience, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Skye Bioscience, Inc. future price: according to them, SKYE price has a max estimate of 25.00 USD and a min estimate of 20.00 USD. Watch SKYE chart and read a more detailed Skye Bioscience, Inc. stock forecast: see what analysts think of Skye Bioscience, Inc. and suggest that you do with its stocks.